Skip to main content

Marex Group plc

Position in CGC — Canopy Growth Corp

CIK 1997464 London, X0

Position in CGC

as of Mar 31, 2026 · filed May 13, 2026
Position Value
$44,007
+$24,032 QoQ
Shares Held
46,373
+183.2% QoQ
Ownership
0.011%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2024
6 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in CGC Over Time

Shares Held

Position Value (USD)

Derivatives in CGC

reported options exposure · as of Mar 31, 2026
CallValue
$0
CallShares
0
PutValue
$42,135
PutShares
44,400

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

Marex Group plc holds $32,136,552 across 11 Drug Manufacturers - Specialty & Generic names. CGC ranks #11 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in CGC

Export CSV
8 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $42,135 44,400
2026-03-31 $44,007 46,373
2025-06-30 $19,975 16,373
2025-06-30 $17,568 14,400
2025-03-31 $55,631 61,133
2024-09-30 $293,701 60,934
2024-06-30 $491,063 76,134
2024-03-31 $122,261 14,167